Epstein RJ - Search Results

1

Tang CS, Epstein RJ. Tang CS, et al. Among authors: epstein rj. PLoS One. 2007 Jul 11;2(7):e603. doi: 10.1371/journal.pone.0000603. PLoS One. 2007. PMID: 17622348 Free PMC article.

2

Intron length and accelerated 3' gene evolution.

Tang CS, Zhao YZ, Smith DK, Epstein RJ. Tang CS, et al. Among authors: epstein rj. Genomics. 2006 Dec;88(6):682-689. doi: 10.1016/j.ygeno.2006.06.017. Epub 2006 Aug 22. Genomics. 2006. PMID: 16928427 Free article.

3

Adaptive Evolution Hotspots at the GC-Extremes of the Human Genome: Evidence for Two Functionally Distinct Pathways of Positive Selection.

Tang CS, Epstein RJ. Tang CS, et al. Among authors: epstein rj. Adv Bioinformatics. 2010;2010:856825. doi: 10.1155/2010/856825. Epub 2010 May 3. Adv Bioinformatics. 2010. PMID: 20454629 Free PMC article.

4

Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.

Wong H, Lau S, Leung R, Chiu J, Cheung P, Wong TT, Liang R, Epstein RJ, Yau T. Wong H, et al. Among authors: epstein rj. Med Oncol. 2012 Sep;29(3):1536-42. doi: 10.1007/s12032-011-0082-y. Epub 2011 Oct 8. Med Oncol. 2012. PMID: 21983862

5

Primary prevention of human papillomavirus-dependent neoplasia: no condom, no sex.

Epstein RJ. Epstein RJ. Eur J Cancer. 2005 Nov;41(17):2595-600. doi: 10.1016/j.ejca.2005.06.023. Epub 2005 Oct 11. Eur J Cancer. 2005. PMID: 16223580

6

Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer.

Wong H, Lau S, Yau T, Cheung P, Epstein RJ. Wong H, et al. Among authors: epstein rj. Br J Cancer. 2010 Apr 27;102(9):1391-6. doi: 10.1038/sj.bjc.6605655. Br J Cancer. 2010. PMID: 20424617 Free PMC article.

7

Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

Chiu J, Yau T, Epstein RJ. Chiu J, et al. Among authors: epstein rj. Support Care Cancer. 2009 Mar;17(3):231-40. doi: 10.1007/s00520-008-0526-x. Epub 2008 Nov 14. Support Care Cancer. 2009. PMID: 19009311 Review.

8

Growth of the Asian health-care market: global implications for the pharmaceutical industry.

Epstein RJ. Epstein RJ. Nat Rev Drug Discov. 2007 Oct;6(10):785-92. doi: 10.1038/nrd2360. Nat Rev Drug Discov. 2007. PMID: 17853900 Review.

9

Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma.

Yau T, Chan P, Wong H, Ng KK, Chok SH, Cheung TT, Lam V, Epstein RJ, Fan ST, Poon RT. Yau T, et al. Among authors: epstein rj. Oncology. 2007;72 Suppl 1:67-71. doi: 10.1159/000111709. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087184

10

Unblocking blockbusters: using boolean text-mining to optimise clinical trial design and timeline for novel anticancer drugs.

Epstein RJ. Epstein RJ. Cancer Inform. 2009 Aug 17;7:231-8. doi: 10.4137/cin.s2666. Cancer Inform. 2009. PMID: 20011464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters